Data updated: Mar 10, 2026
SUMATRIPTAN SUCCINATE
SUMATRIPTAN SUCCINATE
Approved 2009-02-06
24
Indications
--
Phase 3 Trials
17
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2009-02-06
- Routes
- SUBCUTANEOUS, ORAL
- Dosage Forms
- INJECTABLE, TABLET
Companies
PH HEALTH ROXANE Sun Pharma Teva Novartis EUGIA PHARMA NORVIUM BIOSCIENCE IPCA LABS LTD Viatris Hikma ALEMBIC VKT PHARMA Dr. Reddy's ONESOURCE SPECIALTY WATSON LABS WOCKHARDT BIO AG ZHEJIANG ORBION PHARMS ANTARES PHARMA INC Aurobindo Pharma ZYDUS Fresenius Kabi FOSUN PHARMA CHARTWELL MOLECULAR Baxter CAPLIN
Active Ingredient: SUMATRIPTAN SUCCINATE
Website: ↗
SUMATRIPTAN SUCCINATE Approval History
Loading approval history...
What SUMATRIPTAN SUCCINATE Treats
24 FDA approvalsOriginally approved for its first indication in 2009 . Covers 24 distinct patient populations.
- Other (24)
Other
(24 approvals)- • Approved indication (Feb 2009)Label
- • Approved indication (Feb 2009)Letter
- • Approved indication (Mar 2009)Label
- • Approved indication (Jul 2009)
- • Approved indication (Aug 2009)
- • Approved indication (Sep 2009)
- • Approved indication (Oct 2009)Letter
- • Approved indication (Jun 2010)
- • Approved indication (Jul 2010)
- • Approved indication (Aug 2010)
- • Approved indication (Jun 2011)
- • Approved indication (Jun 2012)
- • Approved indication (Apr 2013)
- • Approved indication (May 2013)
- • Approved indication (Sep 2013)
- • Approved indication (Jan 2014)
- • Approved indication (Apr 2014)
- • Approved indication (Dec 2015)
- • Approved indication (Jul 2021)
- • Approved indication (Jan 2023)
- • Approved indication (Nov 2024)
- • Approved indication (Dec 2024)
- • Approved indication (Jul 2025) New
- • Approved indication (Nov 2025) New
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
SUMATRIPTAN SUCCINATE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.